ESC 365 - Catecholaminergic polymorphic ventricular tachycardia: risk modulators in patients treated with beta-blockers

ESC Professional Premium Access

Catecholaminergic polymorphic ventricular tachycardia: risk modulators in patients treated with beta-blockers

Session: Primary arrhythmia syndromes - Device treatment

Topic: Antiarrhythmic Drug Treatment

Speaker: Doctor D. Kukavica (Pavia, IT)

Event: ESC Congress 2022

Congress Presentation

Add to my library

About the speaker

Doctor Deni Kukavica

ICS Maugeri - IRCCS Pavia, Pavia (Italy)

0 follower

3 more presentations in this session

T-wave alternans poorly prognostic in primary prophylactic ICD patients: A prospective EU-CERT-ICD study

Speaker: Doctor A. Pelli (Oulu, FI)

Three dimensional modelling of mutant Kir2.1 channel PIP2 interactions help stratify arrhythmia severity in Andersen Tawil syndrome type 1

Speaker: Mrs L. Gutierrez (Madrid, ES)

Characteristics and prognosis of the catecholamine induced QT prolongation syndrome

Speaker: Professor V. Probst (Nantes, FR)

Access the full session

Primary arrhythmia syndromes - Device treatment

Speakers: Doctor D. Kukavica, Doctor A. Pelli, Mrs L. Gutierrez, Professor V. Probst

About the event

ESC Congress 2022

26 August - 29 August 2022

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources